Stephen OHara - Ingen Technologies Director

Director

Dr. Stephen OHara, M.D., is a Director of Ingen Technologies, Inc. The Consumer Research Council of America, an independent organization based in Washington, D.C. recently ranked Dr. Stephen OHara among the top two percent of clinical neurologists nationwide. He attended Stanford University and graduated in 1975 with a BS degree in biology and performed honors research in the laboratory of Dr. Donald Kennedy, who subsequently served as President of Stanford University. Dr. OHara obtained his M.D. from Northwestern University in 1979, where he became president of the Northwestern chapter of the American Medical Student Association, then proceeded to complete his residency in neurology at UCLA in 1983 since 2005.
Age 56
Tenure 19 years
Professional MarksPh.D
Phone951-688-7840
Webhttps://www.ingen-tech.com
O'Hara is boardcertified in neurology through the American Board of Psychiatry and Neurology. Since completing his residency, Dr. O'Hara has continued to teach the residents in the neurology program at UCLA while maintaining a private practice in Century City, California for the past 16 years with an emphasis on geriatric neurology and disorders of balance.

Similar Executives

Showing other executives

DIRECTOR Age

Steven LorangerEdwards Lifesciences Corp
69
John SununuBoston Scientific Corp
56
Randall HoganMedtronic PLC
64
Nicholas AugustinosDexCom Inc
59
Jay SkylerDexCom Inc
71
Andrea SaiaAlign Technology
60
Nelda ConnorsBoston Scientific Corp
55
Ellen ZaneBoston Scientific Corp
69
Edward LiddyAbbott Laboratories
74
Barbara McNeilEdwards Lifesciences Corp
74
Giovanni CaforioStryker
56
Nicholas ValerianiEdwards Lifesciences Corp
64
Eric TopolDexCom Inc
63
Richard CollinsDexCom Inc
61
Glenn TiltonAbbott Laboratories
72
Kristina JohnsonBoston Scientific Corp
58
Michelle KumbierAbbott Laboratories
53
Christopher BegleyZimmer Biomet Holdings
68
Robert AlpernAbbott Laboratories
70
Paul LaVioletteEdwards Lifesciences Corp
63
Mary BrainerdStryker
67
Ingen Technologies, Inc., a medical device manufacturing company, manufactures medical products for the respiratory industry in United States. Ingen Technologies, Inc. was founded in 1999 and is based in Riverside, California. INGEN TECHNOLOGIES operates under Medical Devices classification in the United States and is traded on PNK Exchange. Ingen Technologies [IGNT] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Ingen Technologies Leadership Team

Elected by the shareholders, the Ingen Technologies' board of directors comprises two types of representatives: Ingen Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ingen. The board's role is to monitor Ingen Technologies' management team and ensure that shareholders' interests are well served. Ingen Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ingen Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Christopher Wirth, Director
Stephen OHara, Director
John Finazzo, Director
Richard Weed, G Counsel
Yong Khoo, Director
Thomas Neavitt, Interim CEO, CFO, Principal Accounting Officer, Controller and Director
Richard Campbell, Director
David Hanson, CEO Director
Charles Vorwaller, Executive VP of National Product Distribution
David Holland, Director
Gary Tilden, Chairman, Chief Operations Officer and Secretary
Curt Miedema, Director
Donn Miller, Director
Michael Cooper, Director

Ingen Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Ingen Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ingen Technologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ingen Technologies' short interest history, or implied volatility extrapolated from Ingen Technologies options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ingen Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Ingen Pink Sheet analysis

When running Ingen Technologies' price analysis, check to measure Ingen Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ingen Technologies is operating at the current time. Most of Ingen Technologies' value examination focuses on studying past and present price action to predict the probability of Ingen Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ingen Technologies' price. Additionally, you may evaluate how the addition of Ingen Technologies to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Please note, there is a significant difference between Ingen Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ingen Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ingen Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.